PolyPid Ltd.
PYPDHealthcare|Biotechnology|IL
$6.14
+0.47 (+8.29%)
DCF Value
$0.12
Tangible Book / Share
$0.24
Cash / Share
$0.29
Clinical Trials (7)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT03558984 D-PLEX 302: Efficacy and Safety of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery | Surgical Site Infection, Sternal Infection | P3 | Terminated | 2 | RCT, Double-blind | D-PLEX |
| NCT04233424 D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection | Surgical Site Infection, Colon Surgery | P3 | Completed | 977 | RCT, Double-blind | D-PLEX, Standard of Care (SoC) |
| NCT04411199 D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II) | Surgical Site Infection, Colon Surgery | P3 | Completed | 975 | RCT, Double-blind | D-PLEX |
| NCT02731573 Safety and Efficacy of D-PLEX in the Prevention of Sternal Infection Post Cardiac Surgery. | Postoperative Wound Infection Superficial Incisional, Postoperative Wound Infection Deep Incisional Surgical Site | P1P2 | Completed | 81 | RCT, Single-blind | D-PLEX |
| NCT03633123 D-PLEX 310: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection | Abdominal Surgery, Colon Surgery | P2 | Completed | 202 | RCT, Double-blind | D-PLEX |
| NCT02531100 BonyPid-500TM Bone Graft Substitute Study | Peri Implantitis | N/A | Completed | 27 | RCT, Single-blind | — |
| NCT02491047 Safety and Performance of BonyPid-1000™ in the Treatment of Gustilo I, II, IIIA and IIIB Tibial Open Fractures | Tibial Fractures, Open Fractures | N/A | Completed | 51 | RCT, Single-blind | — |